Industry Outlook & Insights
The AdvaMed Accel Leadership Seminar provides insights into early and emerging-growth medical technology company executives as they bring innovations to market. Leading medtech CEOs share lessons on managing innovation and preparing businesses for long-term growth and commercialization. The program also features a preview of the MedTech Innovator competition with start-up companies vying for the audience vote and the Virginia Shimer Rybski Memorial Award, presented to the winning company during a networking lunch.
7:30 AM: Registration and Coffee
8:00 AM Welcome Remarks
Martha Shadan, President and CEO, Miach Orthopaedics & Chairwoman, AdvaMed Accel Board of Directors
8:15 AM De-risking MedTech Innovation by Investing in the Process Before the Product
Too many medtech startups fail due to a lack of seed or bridge funding, which results in fewer devices with high value potential entering clinical care and saving lives. Before investing in the product, innovators and the companies and investors that support them need to invest in a capital efficient development process and the people to drive it. During this session, attendees will learn from a panel of experienced company executives and advisors, who will discuss elements of medtech design and development models that de-risk medtech innovation to fail fast and help ensure investments are made in products with a higher likelihood of successful, capital efficient commercialization. Through an interactive audience discussion, panelists will also share their knowledge of successful commercialization approaches.
Moderator: Paul Snyder, Vice President Healthcare, Write2Market
Scott Drake, President and CEO, ViewRay, Inc. (invited)
Benjamin Glenn, Partner, Shay Glenn LLP
Dev Kurdikar, President and Chief Executive Officer, Cardiac Science Corporation
Tiffany Wilson, CEO, Global Center for MedTech Innovation (GCMI)
9:15 AM Networking Break
9:30 AM Integrating Health Economics and Outcome Research Into the Product Development Cycle
The probability of reimbursement is a key factor in determining whether to proceed with a product during its development. Medical devices companies have often outsourced this work in the past, waiting until after the clinical results for regulatory purposes before they invest in HEOR and market access internally. In this session, we will discuss why this later-stage approach can undermine the success of a product launch, and how early stage companies are finding value by beginning HEOR and market access planning much earlier in the R&D cycle.
Moderator: Deepak Sahu, Manager, Alira Health
Matt Benessere, Director, Global Market Access, Insulet
Arthi Chandran, Vice President and Head of WW Health Economics and Outcomes Research, BD
Martin Gold, Senior Director, Health Economics and Market Development, Integra LifeSciences
Maria Stewart, Global Vice President, Health Economics and Market Access, Boston Scientific
10:30 AM Networking Break
10:45 AM MedTech Innovator: Preliminary Competition and Execution Award
A select group of MedTech Innovator Semi-Finalists companies will pitch for the audience vote in the MedTech Innovator Execution Competition, presented to the company in the Accelerator Program that demonstrates the strongest execution plan and potential. The winner will receive the Virginia Shimer Rybski Memorial Award.
As a scientist and serial entrepreneur, Virginia Shimer Rybski worked for and founded several companies before becoming the President and CEO of Regenesis Biomedical, Inc. In the spirit of this dynamic woman, this award was created by AdvaMed Accel in 2013 to encourage the enthusiastic pursuit of business excellence in the medical technology industry and recognize the potential of a promising entrepreneurial company.
Host: Paul Grand, Chief Executive Officer MedTech Innovator
11:45 AM Networking Luncheon - Sponsored by Medmarc
MedTech Innovator Execution Award Ceremony
Virginia Shimer Rybski Memorial Award
Presented by: Paul Grand, Chief Executive Officer, MedTech Innovator
George Ayd, Assistant Vice President, Business Development and Marketing, Medmarc
1:00 PM Adjourn